Roth Capital raised the firm’s price target on Gentherm (THRM) to $44 from $42 and keeps a Buy rating on the shares. The company’s Q3 execution was good, with Gentherm turning in modest outperformance of industry production in core climate/comfort products while absorbing higher material and footprint realignment costs, resulting in an adjusted EBITDA beat, the analyst tells investors in a research note. Awards for Gentherm also remain strong, with conquest lumbar/massage wins driving good new program bookings, Roth added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THRM:
